Page last updated: 2024-10-24

carisoprodol and Cerebral Palsy, Athetoid

carisoprodol has been researched along with Cerebral Palsy, Athetoid in 10 studies

Carisoprodol: A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
carisoprodol : A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
PHELPS, WM	2
SPEARS, CE	1
GOLDSTEIN, H	1
ARGY, WP	2
WOODS, GE	2
GOOCH, JM	1
CUCHE, J	1
MINASSIAN, J	1
Campbell, ED	1
Green, EA	1

Other Studies

10 other studies available for carisoprodol and Cerebral Palsy, Athetoid

Article	Year
Preliminary institutional evaluation of a new drug in cerebral palsy: N-isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate (soma). Archives of pediatrics, 1959, Volume: 76, Issue:6 Topics: Carisoprodol; Cerebral Palsy; Health Facilities; Muscle Relaxants, Central; Propylene Glycol; Propyl	1959
Preliminary trial of a new muscle relaxant; nisopropyl-2-methyl-2-propyl-1,3 propanediol dicarbamate (soma) in outpatient children with cerebral palsy. Archives of pediatrics, 1959, Volume: 76, Issue:7 Topics: Carisoprodol; Cerebral Palsy; Muscle Relaxants, Central; Outpatients; Propylene Glycol; Propylene Gl	1959
Carisoprodol in the treatment of children with motor difficulties due to brain impairment. Archives of pediatrics, 1961, Volume: 78 Topics: Brain; Cardiovascular Agents; Carisoprodol; Cerebral Palsy; Child; Infant; Movement Disorders; Muscl	1961
Carisoprodol (soma); muscle relaxant properties in children with cerebral palsy. Georgetown medical bulletin, 1960, Volume: 13 Topics: Cardiovascular Agents; Carisoprodol; Cerebral Palsy; Muscle Relaxants, Central; Neurons	1960
Clinical evaluation of carisoprodol in cerebral palsy. Annals of the New York Academy of Sciences, 1960, Mar-30, Volume: 86 Topics: Cardiovascular Agents; Carisoprodol; Cerebral Palsy; Muscle Relaxants, Central	1960
Double-blind trial of carisoprodol. Developmental medicine and child neurology, 1962, Volume: 4 Topics: Athetosis; Carisoprodol; Cerebral Palsy; Double-Blind Method; Humans	1962
Preliminary clinical trial of carisoprodol in infantile cerebral palsy. Developmental medicine and child neurology, 1962, Volume: 4 Topics: Carisoprodol; Cerebral Palsy; Humans; Muscle Relaxants, Central	1962
CARISOPRODOL IN CEREBRAL PALSY: A CONTROLLED TRIAL. Developmental medicine and child neurology, 1963, Volume: 5 Topics: Amobarbital; Carisoprodol; Cerebral Palsy; Child; Humans; Infant, Newborn; Placebos	1963
[ON THE USE OF A MUSCLE RELAXANT WITH ANALGESIC ACTION IN CHILDREN]. Lyon medical, 1963, Oct-06, Volume: 210 Topics: Adolescent; Analgesia; Analgesics; Bone Diseases; Carisoprodol; Casts, Surgical; Cerebral Palsy; Chi	1963
Treatment of cerebral palsy in the severely subnormal. Rheumatology and physical medicine, 1970, Volume: 10, Issue:8 Topics: Carisoprodol; Cerebral Palsy; Child; Child, Preschool; Diazepam; Female; Humans; Hydrotherapy; Intel	1970